952 related articles for article (PubMed ID: 17023807)
1. Prevalence of evaluation and treatment of glucocorticoid-induced osteoporosis in men.
Cruse LM; Valeriano J; Vasey FB; Carter JD
J Clin Rheumatol; 2006 Oct; 12(5):221-5. PubMed ID: 17023807
[TBL] [Abstract][Full Text] [Related]
2. Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update. American College of Rheumatology Ad Hoc Committee on Glucocorticoid-Induced Osteoporosis.
Arthritis Rheum; 2001 Jul; 44(7):1496-503. PubMed ID: 11465699
[TBL] [Abstract][Full Text] [Related]
3. Screening and treatment of glucocorticoid-induced osteoporosis in rheumatoid arthritis patients in an urban multispecialty practice.
Ledwich LJ; Clarke K
J Clin Rheumatol; 2009 Mar; 15(2):61-4. PubMed ID: 19265346
[TBL] [Abstract][Full Text] [Related]
4. Glucocorticoid-induced osteoporosis: a review on pathophysiology and treatment options.
De Nijs RN
Minerva Med; 2008 Feb; 99(1):23-43. PubMed ID: 18299694
[TBL] [Abstract][Full Text] [Related]
5. What is new in the treatment of steroid-induced osteoporosis?
Liu RH; Werth VP
Semin Cutan Med Surg; 2007 Dec; 26(4):203-9. PubMed ID: 18395668
[TBL] [Abstract][Full Text] [Related]
6. Management of glucocorticoid-induced osteoporosis in patients with rheumatoid arthritis: rates and predictors of care in an academic rheumatology practice.
Solomon DH; Katz JN; Jacobs JP; La Tourette AM; Coblyn J
Arthritis Rheum; 2002 Dec; 46(12):3136-42. PubMed ID: 12483716
[TBL] [Abstract][Full Text] [Related]
7. Effects of bisphosphonate administration on the bone mass in immune thrombocytopenic purpura patients under treatment with steroids.
Nomura S; Kurata Y; Tomiyama Y; Takubo T; Hasegawa M; Saigo K; Nishikawa M; Higasa S; Maeda Y; Hayashi K
Clin Appl Thromb Hemost; 2010 Dec; 16(6):622-7. PubMed ID: 19959489
[TBL] [Abstract][Full Text] [Related]
8. A cost effectiveness analysis of calcium and vitamin D supplementation, etidronate, and alendronate in the prevention of vertebral fractures in women treated with glucocorticoids.
Buckley LM; Hillner BE
J Rheumatol; 2003 Jan; 30(1):132-8. PubMed ID: 12508402
[TBL] [Abstract][Full Text] [Related]
9. Glucocorticoid-induced osteoporosis.
Berris KK; Repp AL; Kleerekoper M
Curr Opin Endocrinol Diabetes Obes; 2007 Dec; 14(6):446-50. PubMed ID: 17982350
[TBL] [Abstract][Full Text] [Related]
10. Once-weekly oral alendronate 70 mg in patients with glucocorticoid-induced bone loss: a 12-month randomized, placebo-controlled clinical trial.
Stoch SA; Saag KG; Greenwald M; Sebba AI; Cohen S; Verbruggen N; Giezek H; West J; Schnitzer TJ
J Rheumatol; 2009 Aug; 36(8):1705-14. PubMed ID: 19487264
[TBL] [Abstract][Full Text] [Related]
11. Prevention and treatment of glucocorticoid-induced osteoporosis: a comparison of calcitriol, vitamin D plus calcium, and alendronate plus calcium.
Sambrook PN; Kotowicz M; Nash P; Styles CB; Naganathan V; Henderson-Briffa KN; Eisman JA; Nicholson GC
J Bone Miner Res; 2003 May; 18(5):919-24. PubMed ID: 12733733
[TBL] [Abstract][Full Text] [Related]
12. Suggested guidelines for evaluation and treatment of glucocorticoid-induced osteoporosis for the Department of Veterans Affairs.
Adler RA; Hochberg MC
Arch Intern Med; 2003 Nov; 163(21):2619-24. PubMed ID: 14638562
[TBL] [Abstract][Full Text] [Related]
13. Understanding treatments for bone loss and bone metastases in patients with prostate cancer: a practical review and guide for the clinician.
Higano CS
Urol Clin North Am; 2004 May; 31(2):331-52. PubMed ID: 15123412
[TBL] [Abstract][Full Text] [Related]
14. Trends in prevention of glucocorticoid-induced osteoporosis.
Saag KG; Gehlbach SH; Curtis JR; Youket TE; Worley K; Lange JL
J Rheumatol; 2006 Aug; 33(8):1651-7. PubMed ID: 16845707
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and determinants of osteoporosis drug prescription among patients with high exposure to glucocorticoid drugs.
Ettinger B; Chidambaran P; Pressman A
Am J Manag Care; 2001 Jun; 7(6):597-605. PubMed ID: 11439733
[TBL] [Abstract][Full Text] [Related]
16. In whom and how to prevent glucocorticoid-induced osteoporosis.
Adachi JD; Papaioannou A
Best Pract Res Clin Rheumatol; 2005 Dec; 19(6):1039-64. PubMed ID: 16301196
[TBL] [Abstract][Full Text] [Related]
17. [Guidelines for the treatment of glucocorticoid-induced osteoporosis and their future problems].
Soen S
Clin Calcium; 2006 Nov; 16(11):1788-96. PubMed ID: 17079844
[TBL] [Abstract][Full Text] [Related]
18. Patient knowledge, beliefs, and behavior concerning the prevention and treatment of glucocorticoid-induced osteoporosis.
Blalock SJ; Norton LL; Patel RA; Dooley MA
Arthritis Rheum; 2005 Oct; 53(5):732-9. PubMed ID: 16208664
[TBL] [Abstract][Full Text] [Related]
19. Glucocorticoid-induced osteoporosis: unawareness or negligence in India?
Gera C; Vij AS
Int J Rheum Dis; 2009 Sep; 12(3):230-3. PubMed ID: 20374351
[TBL] [Abstract][Full Text] [Related]
20. Quality assurance study of the use of preventative therapies in glucocorticoid-induced osteoporosis in early inflammatory arthritis: results from the CATCH cohort.
McKeown E; Bykerk VP; De Leon F; Bonner A; Thorne C; Hitchon CA; Boire G; Haraoui B; Ferland DS; Keystone EC; Pope JE;
Rheumatology (Oxford); 2012 Sep; 51(9):1662-9. PubMed ID: 22539481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
